References
- Gray J W, Dolbeare F, Pallavicini M G, Vanderlaan M. Flow cytokinetics. Techniques in cell cycle analysis, J W Gray, Z Darzynkiewicz. Humana Press, Clifton, New Jersey 1987
- Gratzner H G. Monoclonal antibody to 5-bromo- and 5-iodo-deoxyuridine: a new reagent for detection of DNA replication. Science 1982; 218: 474–5
- Wilson G D, McNally N J, Dische S. Measurement of cell kinetics in human tumors in vivo using bromodeoxyuridine incorporation and flow cytometry. Br J Cancer 1988; 58: 423–31
- Wilson G D, McNally N J. Measurement of cell proliferation using bromodeoxyuridine. Assessment of cell proliferation in clinical practice, P A Hall, D A Levison, N A Wright. Springer-Verlag London Ltd. 1992
- Dolbeare F, Gratzner H, Pallavicini M G, Gray J W. Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine. Proc Natl Acad Sci USA 1983; 80: 5573–7
- Steel G G. Growth kinetics of tumors. Oxford University Press, London 1977
- Ritter M A, Fowler J F, Kim Y. Single biopsy, tumor kinetic analyses: a comparison of methods and an extension to shorter sampling intervals. Int J Radiat Oncol Biol Phys 1992; 23: 811–20
- Begg A C, Hofland I, Moonen L. The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumors: an interim report. Int J Radiat Oncol Biol Phys 1990; 19: 1449–53
- Bennett M H, Wilson G D, Dische S. Tumor proliferation assessed by combined histological and flow cytometric analysis: implications for therapy in squamous cell carcinoma in the head and neck. Br J Cancer 1992; 65: 870–8
- Lochrin C A, Wilson G D, McNally N J. Tumor cell kinetics, local tumor control, and accelerated radiotherapy: a preliminary report. Int J Radiat Oncol Biol Phys 1992; 24: 87–91
- Forster G, Cooke T G, Cooke L D. Tumor growth rates in squamous carcinoma of the head and neck measured by in vivo bromodeoxyuridine incorporation and flow cytometry. Br J Cancer 1992; 65: 698–702
- Wilson G D. Assessment of human tumor proliferation using bromodeoxyuridine—current status. Acta Oncol 1991; 30: 903–10
- McNally N J, Wilson G D, Martindale C A. Tumor and cellular radiobiology. 1991 annual report of the Cancer Research Campaign Gray Laboratory, including the report of the Mount Vernon Centre for Cancer Treatment. 1991
- Stell P M. Prognosis in laryngeal carcinoma: host factors. Clin Otolaryngol 1990; 15: 111–9
- Kaplan M J, Johns M E, Clark D A. Glottic carcinoma: the roles of surgery and irradiation. Cancer 1984; 53: 2641–8
- Dische S, Saunders M I, Wilson G D, McNally N J. Cell proliferation and differentiation in squamous cancer. Radiother Oncol 1989; 15: 19–23
- Kearsley J H, Bryson G, Battistutta D, Collins R J. Prognostic importance of cellular DNA content in head-and-neck squamous cell cancers. A comparison of retrospective and prospective series. Int J Cancer 1991; 47: 31–7
- Tubiana M, Courdi A. Cell proliferation kinetics in human solid tumors: relation to probability of metastatic dissemination and long-term survival. Radiother Oncol 1989; 15: 1–18
- Begg A C, Moonen L, Hofland I, Dessing M, Bartelink H. Human tumor cell kinetics using a monoclonal antibody against iododeoxyuridine: Intratumor sampling variations. Radiother Oncol 1988; 11: 337–47
- IUCC. TNM classification of malignant tumors, P Hermanek, L H Sobin. Springer Ver-lag, Berlin, Heidelberg; New York 1987
- Anneroth G, Batsakis J, Luna M. Review of the literature and a recommended system of malignancy grading in oral squamous cell carcinomas. Scand J Dent Res 1987; 95: 229–49
- Hoshino T, Nagashima T, Murovic J. Cell kinetic studies of in situ human brain tumors with bromodeoxyuridine. Cytometry 1985; 6: 627–32
- International Commission on Radiation Units and Measurements (ICRU). Determination of absorbed dose in patient irradiated by beams of x or gamma rays in radiotherapy procedures. ICRU, Washington 1976, Report No 24
- Chauvel P, Courdi A, Gioanni J. The labelling index: a prognostic factor in head and neck carcinoma. Radiother Oncol 1989; 14: 231–7
- Fowler J F. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989; 62: 679–94
- Saunders M I, Dische S, Fowler J F. Radiotherapy employing three fractions on each of twelve consecutive days. Acta Oncol 1988; 27: 163–7